Gainers
- Oriental Culture Holding LTD (NASDAQ: OCG) rose 110.5% to $12.84 in pre-market trading. Oriental Cultural, on Tuesday, priced its IPO at $4 per share.
- Scopus BioPharma Inc. (NASDAQ: SCPS) rose 70.4% to $10.09 in pre-market trading. Scopus Biopharma shares gained around 8% on Wednesday after the company priced its IPO at $5.5 per share.
- Nxt-ID, Inc. (NASDAQ: NXTD) rose 48.3% to $1.37 in pre-market trading after jumping around 90% on Wednesday.
- Wunong Net Technology Company Limited (NASDAQ: WNW) shares rose 30.1% to $84.68 in pre-market trading after jumping 440% on Wednesday. The company, on Tuesday, priced its IPO at $5 per share.
- Marathon Patent Group, Inc.. (NASDAQ: MARA) rose 22.8% to $10.10 in pre-market trading after surging 16% on Wednesday.
- Canaan Inc. (NASDAQ: CAN) rose 18.7% to $4.51 in pre-market trading after gaining around 7% on Wednesday.
- 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 17.3% to $0.8855 in pre-market trading. OrbiMed Israel BioFund GP Limited Partnership reported a 16% stake in 9 Meters Biopharma.
- Vivos Therapeutics, Inc. (NASDAQ: VVOS) rose 16.7% to $7.91 in pre-market trading. Vivos Therapeutics, earlier during the month, priced its IPO at $6 a share.
- Bit Digital, Inc. (NASDAQ: BTBT) shares rose 16.4% to $5.88 in pre-market trading following an 18% decline on Wednesday. Bit Digital, earlier during the month, highlighted completion of acquisition of $13,902,742 worth of bitcoin miners with total hash rate of 1,003.5 Ph/s.
- ORBCOMM Inc. (NASDAQ: ORBC) shares rose 16.3% to $7.79 in pre-market trading. ORBCOM, last week, won a $45.6 million contractfFrom the Department of Army titled ‘Next Generation Transponder.’
- Skillful Craftsman Education Technology Limited (NASDAQ: EDTK) rose 16% to $3.36 in pre-market trading.
- MacroGenics, Inc. (NASDAQ: MGNX) rose 15.8% to $28.60 in pre-market trading after the company announced FDA approval of MARGENZA for patients with pretreated metastatic HER2-positive breast cancer.
- Celsion Corporation (NASDAQ: CLSN) rose 11.9% to $0.7495 in pre-market trading after declining over 5% on Wednesday.
- NeuroMetrix, Inc. (NASDAQ: NURO) rose 11.9% to $2.91 in pre-market trading after declining 8% on Wednesday. The company was recently granted U.S. patent titled ‘Transcutaneous electrical nerve stimulation using novel unbalanced biphasic waveform and novel electrode arrangement.’
- Atossa Therapeutics, Inc. (NASDAQ: ATOS) shares rose 11.5% to $1.07 in pre-market trading after gaining around 10% on Wednesday. Atossa Therapeutics, last week, priced a $20 million underwritten public offering.
- Enlivex Therapeutics Ltd. (NASDAQ: ENLV) rose 10.8% to $11.35 in pre-market trading. Enlivex, earlier during the month, reported issuance of new Chinese patent…
Read More: 42 Stocks Moving in Thursday’s Pre-Market Session